OMEROS CORP (OMER)
Omeros Corporation is a biopharmaceutical firm with commercialized products, actively engaged in the discovery, development, and market introduction of both small-molecule and protein-based therapies, including treatments for rare diseases. The company's therapeutic endeavors primarily focus on inflammatory conditions, illnesses mediated by the complement system, cancers linked to immune system dysregulation, and disorders characterized by addiction or compulsion. Its robust clinical pipeline features several promising candidates. Narsoplimab (also known as OMS721 or MASP-2), a leading asset, has successfully concluded pivotal trials for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA). This drug is also currently undergoing Phase III clinical evaluation for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS), in addition to a Phase II trial investigating its potential for treating COVID-19. Further expanding its clinical portfolio, Omeros is developing PPAR? (OMS405) in Phase II for opioid and nicotine dependence. PDE7 (OMS527) is progressing through Phase I studies for addiction, compulsive disorders, and movement disorders. Additionally, MASP-3 (OMS906) is currently in Phase I trials for paroxysmal nocturnal hemoglobinuria (PNH) and other conditions involving the alternative complement pathway. Beyond its clinical efforts, the company maintains a dynamic preclinical program. This includes small-molecule inhibitors targeting MASP-2, which are being explored for applications in aHUS, IgAN, HSCT-TMA, and age-related macular degeneration. Also in development is a next-generation, longer-acting antibody that targets MASP-2, alongside MASP-3 small-molecule inhibitors designed to address PNH and other alternative pathway disorders. Omeros's preclinical research further encompasses GPR174 inhibitors, as well as Chimeric Antigen Receptor (CAR) T-Cell and Adoptive T-Cell Therapies for various oncological indications. The company is also investigating G protein-coupled receptor targets for a broad spectrum of diseases, including immunological, immuno-oncological, metabolic, central nervous system (CNS), cardiovascular, musculoskeletal, and other conditions. Established in 1994, Omeros Corporation is headquartered in Seattle, Washington.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Omeros Corporation
NASDAQ:OMERHealthcare · Biotechnology
-2.69%$18.44
AH$18.45+0.05%vs close
Mkt Cap$1.33B
Float64.19M
O/S72.39M
Vol
$ Vol
RVOL
Inst Own49.9%
SI17.8%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$3.35M
Total Assets$325.63M
Free Cash Flow-$116.16M
Debt & Equity
Debt 203%
Total Debt$239.14M
Total Equity-$121.23M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in OMER's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$325.63M
Liabilities$446.86M
Accounts Receivable$36.27M
Accounts Payable$4.76M
Inventory$0
PP&E (Net)$12.48M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $111.81M | $29.87M | $64.83M | $41.62M | $13.51M | $539K | $1.6M | $6.02M | $4.52M | $2.1M | $1.44M | $1.17M | $1.92M | $200K | $0 |
| YoY Growth | - | - | - | - | - | - | 274.3% | -53.9% | 55.8% | 208.1% | 2406.3% | -66.3% | -73.4% | 33.1% | 114.9% | 45.8% | 23.4% | -39.2% | 861.5% | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $1.39M | $1.62M | $2.65M | $512K | $1.08M | $1.41M | $1.04M | $26.73M | $18.33M | $18K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | -$1.39M | -$1.62M | $109.15M | $29.36M | $63.75M | $40.2M | $12.47M | -$26.19M | -$16.73M | $6M | $4.52M | $2.1M | $1.44M | $1.17M | $1.92M | $200K | $0 |
| Gross Margin | - | - | - | - | - | - | 97.6% | 98.3% | 98.3% | 96.6% | 92.3% | -4858.8% | -1045.4% | 99.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | - |
| Research and Development | $81.3M | $119.52M | $114.87M | $112.72M | $118.78M | $107.61M | $109.7M | $89.86M | $55.6M | $50.7M | $48.38M | $47.95M | $36.3M | $31.92M | $23.72M | $23.46M | $16.93M | $17.85M | $15.92M | $20.53M | $5.8M |
| Selling, General, and Administrative | $41.5M | $49.73M | $49.66M | $50.67M | $53.46M | $47.69M | $62.84M | $51.72M | $52.04M | $43.78M | $35.33M | $22.6M | $15.82M | $10.98M | $8.22M | $8.75M | $5.27M | $7.84M | $10.4M | $3.63M | $1.9M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $945K | $0 | -$207K | $574K | $130K | $0 | $0 | $0 | $0 | -$125K | $179K | $0 |
| Total Operating Expenses | $122.8M | $169.26M | $164.53M | $163.39M | $172.23M | $155.3M | $172.53M | $141.58M | $107.64M | $94.48M | $83.71M | $70.55M | $52.12M | $42.91M | $31.93M | $32.21M | $22.2M | $25.7M | $26.32M | $24.15M | $7.71M |
| Operating Income (EBIT) | -$122.8M | -$169.26M | -$164.53M | -$163.39M | -$173.62M | -$156.92M | -$63.38M | -$112.22M | -$43.9M | -$54.28M | -$71.24M | -$70.01M | -$50.52M | -$36.88M | -$27.41M | -$30.11M | -$20.76M | -$24.52M | -$24.4M | -$23.95M | -$7.71M |
| Operating Margin | - | - | - | - | - | - | -56.7% | -375.7% | -67.7% | -130.4% | -527.3% | -12988.5% | -3157.3% | -612.5% | -605.9% | -1430.2% | -1437.5% | -2096.2% | -1268.7% | -11976.5% | - |
| Interest Expense | $0 | $24.68M | $30.84M | $22.7M | $19.67M | $26.75M | $22.66M | $16.25M | $11.03M | $7.82M | $3.57M | $3.47M | $2.37M | $1.73M | $1.88M | $1.53M | $2.2M | $335K | $151K | $91K | $0 |
| Interest Income | $5.06M | $11.3M | $16.34M | $4.06M | $18K | $654K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $333K |
| Other Income (Expense) | $120M | -$13.37M | -$10.39M | -$18.64M | -$17.93M | -$39.47M | -$21.1M | -$27.46M | -$9.59M | -$12.47M | -$3.86M | -$3.67M | $10.72M | -$1.56M | -$1.14M | $855K | -$331K | $698K | $1.31M | $1.18M | $341K |
| Income Before Tax (EBT) | -$2.8M | -$182.63M | -$174.92M | -$182.03M | -$191.55M | -$196.39M | -$84.49M | -$139.69M | -$53.48M | -$66.75M | -$75.1M | -$73.67M | -$39.8M | -$38.44M | -$26.66M | -$27.72M | -$18.89M | -$23.83M | -$23.09M | -$22.78M | -$7.37M |
| Income Tax Expense | $2.01M | $0 | $0 | $0 | $0 | -$23.26M | $0 | -$12.93M | $0 | $0 | $0 | $0 | $0 | $0 | $1.14M | -$855K | $331K | $0 | $26K | $0 | $0 |
| Net Income | -$3.35M | -$156.81M | -$117.81M | $47.42M | -$111.41M | -$138.06M | -$84.49M | -$126.76M | -$53.48M | -$66.75M | -$75.1M | -$73.67M | -$39.8M | -$38.44M | -$28.55M | -$29.25M | -$21.09M | -$23.83M | -$23.09M | -$22.78M | -$7.37M |
| Net Income Margin | - | - | - | - | - | - | -75.6% | -424.4% | -82.5% | -160.4% | -555.9% | -13668.5% | -2487.3% | -638.4% | -631.0% | -1389.6% | -1460.5% | -2036.5% | -1200.8% | -11388.5% | - |
| Supplementary Data | |||||||||||||||||||||
| EPS | -0.05 | -2.70 | -1.88 | 0.46 | -1.79 | -2.41 | -2.16 | -2.61 | -1.17 | -1.65 | -2.00 | -2.22 | -1.39 | -1.59 | -1.29 | -1.37 | -2.92 | -2.22 | -1.62 | -1.60 | -0.52 |
| Diluted EPS | -0.05 | -2.70 | -1.88 | 0.46 | -1.79 | -2.41 | -2.16 | -2.61 | -1.17 | -1.65 | -2.00 | -2.22 | -1.39 | -1.59 | -1.29 | -1.37 | -2.92 | -2.22 | -1.62 | -1.60 | -0.52 |
| Weighted Average OS | 63.51M | 58.17M | 62.74M | 62.74M | 62.34M | 57.18M | 49.52M | 48.58M | 45.54M | 40.45M | 37.56M | 33.23M | 28.56M | 24.16M | 22.21M | 21.42M | 7.22M | 10.75M | 14.27M | 14.27M | 14.27M |
| EBITDA | -$1.83M | -$157M | -$143.16M | -$158.38M | -$170.49M | -$168.02M | -$60.04M | -$122.47M | -$41.9M | -$58.63M | -$71.31M | -$69.88M | -$37.13M | -$36.4M | -$26.23M | -$27.24M | -$18.44M | -$24.09M | -$22.57M | -$22.45M | -$7.37M |
| EBITDA Margin | - | - | - | - | - | - | -53.7% | -410.0% | -64.6% | -140.9% | -527.9% | -12964.2% | -2320.5% | -604.4% | -579.7% | -1294.3% | -1276.7% | -2059.1% | -1173.4% | -11227.0% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 |
| Assets | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash and Cash Equivalents | $9.66M | $3.4M | $7.11M | $11.01M | $100.81M | $10.5M | $3.08M | $5.86M | $3.39M | $2.22M | $1.36M | $354K | $1.38M | $1.52M | $4M | $3.28M | $820K | $12.73M | $5.92M |
| Short-Term Investments | $162.14M | $86.73M | $164.74M | $183.91M | $56.46M | $124.45M | $57.7M | $54.64M | $80.36M | $43.11M | $26.9M | $6.53M | $12.72M | $20.83M | $20.57M | $38.72M | $59.48M | $7.26M | $18.16M |
| Cash and Short-Term Investments | $171.8M | $90.13M | $171.85M | $194.92M | $157.27M | $134.95M | $60.79M | $60.5M | $83.75M | $45.33M | $28.26M | $6.89M | $14.1M | $22.35M | $24.57M | $41.99M | $60.3M | $19.98M | $24.08M |
| Accounts Receivable | $36.27M | $36.82M | $6.72M | $242.02M | $82.47M | $3.84M | $35.19M | $22.82M | $17.14M | $12.04M | $6.52M | $392K | $379K | $1.93M | $876K | $1.48M | $248K | $207K | $190K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $1.35M | $1.15M | $52.51M | $443K | $1.13M | $472K | $568K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $7.59M | $7.17M | $30.75M | $6.3M | $67K | $681K | $6.63M | $6.46M | $0 | $0 | $0 | $120K | $86K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $215.67M | $134.12M | $217.9M | $443.24M | $247.96M | $151.28M | $103.75M | $89.87M | $108.37M | $60.26M | $37.15M | $9.16M | $14.82M | $24.7M | $25.95M | $43.75M | $60.66M | $20.48M | $24.46M |
| Long-Term Assets | |||||||||||||||||||
| Property, Plant & Equipment Net | $12.48M | $17.64M | $20.58M | $23.25M | $30.01M | $28.08M | $30.91M | $3.85M | $2.12M | $1.18M | $951K | $782K | $939K | $1.04M | $739K | $1.62M | $1.09M | $918K | $839K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $60K | $164K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $1.15M | $1.15M | $5.83M | $5.83M | $10.68M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $97.49M | $125.32M | $139.79M | $124.48M | $141.31M | $1.68M | $1.16M | $1.07M | $0 | $0 | $219K | $1.15M | $779K | $838K | $295K | $328K | $312K | $225K | $1.7M |
| Total Long-Term Assets | $109.97M | $142.96M | $160.37M | $147.73M | $171.31M | $29.76M | $33.22M | $6.07M | $7.96M | $7.02M | $11.85M | $1.93M | $1.72M | $1.88M | $1.03M | $1.95M | $1.4M | $1.2M | $2.7M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $325.63M | $277.08M | $378.27M | $590.97M | $419.27M | $181.04M | $136.97M | $95.94M | $116.33M | $67.28M | $48.99M | $11.09M | $16.54M | $26.57M | $26.98M | $45.7M | $62.06M | $21.68M | $27.16M |
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Accounts Payable | $4.76M | $5.91M | $7.71M | $5.99M | $13.4M | $4.2M | $5.33M | $6.28M | $6.69M | $2.52M | $6.43M | $4.92M | $2.33M | $2.63M | $2M | $2.4M | $2.62M | $1.23M | $2.57M |
| Short-Term Debt | $17.06M | $21M | $8.58M | $94.38M | $0 | $0 | $3.5M | $0 | $0 | $0 | $0 | $6.45M | $5.6M | $0 | $5.89M | $395K | $4.93M | $16.56M | $1.01M |
| Current Income Tax Payable | $0 | $0 | $0 | $4.87M | $338K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $2.47M | $0 | $0 | $0 | $0 | $0 | $0 | -$889K | -$490K | -$198K | $0 | $0 | $0 | $970K | $5.75M | $8.01M | $702K | $232K | $500K |
| Other Current Liabilities | $30.89M | $29.51M | $0 | $7.82M | $3.71M | $3.95M | $43.08M | $28.36M | $17.44M | $9M | $2.59M | $0 | $0 | $1.42M | $4.98M | $4.09M | $0 | $1.78M | $1.56M |
| Total Current Liabilities | $78.06M | $79.53M | $53.32M | $136.38M | $51.79M | $36.74M | $55.46M | $37.36M | $26.31M | $16.07M | $16.25M | $18.43M | $11.87M | $9.32M | $18.98M | $15.87M | $11.09M | $23.56M | $7.93M |
| Long-Term Liabilities | |||||||||||||||||||
| Long-Term Debt | $208.53M | $166.58M | $329.7M | $220.91M | $313.46M | $236.29M | $158.21M | $148.98M | $83.31M | $79.51M | $49.77M | $26.26M | $14.9M | $20.1M | $13.55M | $9.36M | $7.83M | $118K | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $153.02M | $200.11M | $2.09M | $125.57M | $1.11M | $0 | $0 | $8.18M | $8.72M | $8.82M | $9M | $9.05M | $8.15M | $3.69M | $0 | $0 | $0 | $89.17M | $89.17M |
| Total Long-Term Liabilities | $368.8M | $380.16M | $349.94M | $368.9M | $343.7M | $265.06M | $190.53M | -$41.58M | $92.83M | $88.65M | $58.98M | $35.31M | $23.05M | $231.83M | $13.55M | $9.36M | $7.83M | $89.29M | $89.17M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $446.86M | $459.69M | $403.25M | $505.29M | $395.49M | $301.79M | $245.99M | -$4.22M | $119.14M | $104.72M | $75.23M | $53.74M | $34.92M | $241.15M | $32.54M | $25.23M | $18.92M | $112.85M | $97.1M |
| Stockholders' Equity | |||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4K |
| Common Stock | $716K | $580K | $611K | $628K | $626K | $616K | $542K | $490K | $482K | $438K | $380K | $342K | $304K | $259K | $224K | $219K | $213K | $57K | $56K |
| Retained Earnings | -$913.7M | -$910.35M | -$753.53M | -$635.72M | -$683.13M | -$872.67M | -$734.61M | $650.13M | -$523.37M | -$469.89M | -$403.14M | -$328.05M | -$254.37M | -$214.58M | -$176.13M | -$147.59M | -$118.34M | -$97.25M | -$73.42M |
| Comprehensive Income & Other | $0 | $0 | -$0 | $0 | $0 | $0 | $0 | -$4.25M | -$3.28M | -$2.73M | -$2.43M | -$2.23M | -$2.09M | -$1.79M | -$2.48M | -$2.08M | $41K | -$99K | -$4K |
| Other Stockholders' Equity | $791.75M | $727.16M | $727.94M | $720.77M | $706.29M | $751.3M | $625.05M | -$490K | $520.07M | $432M | $376.53M | $285.05M | $235.69M | -$259K | $170.35M | $167.84M | $161.27M | $6.02M | $3.42M |
| Total Equity | -$121.23M | -$182.61M | -$24.98M | $85.68M | $23.78M | -$120.75M | -$109.02M | $650.13M | -$2.81M | -$37.45M | -$26.23M | -$42.65M | -$18.38M | -$214.58M | -$5.55M | $20.47M | $43.15M | -$91.17M | -$69.94M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $325.63M | $277.08M | $378.27M | $590.97M | $419.27M | $181.04M | $136.97M | $645.9M | $116.33M | $67.28M | $48.99M | $11.09M | $16.54M | $26.57M | $26.98M | $45.7M | $62.06M | $21.68M | $27.16M |
| Supplementary Data | |||||||||||||||||||
| Total Debt | $239.14M | $207.02M | $361.58M | $342.02M | $347.84M | $268.84M | $194.03M | $151.45M | $84.61M | $80.03M | $50.05M | $32.71M | $20.5M | $20.1M | $19.45M | $9.76M | $12.76M | $16.67M | $1.01M |
| Net Debt | $229.48M | $203.62M | $354.48M | $331.01M | $247.03M | $258.34M | $190.95M | $145.59M | $81.21M | $77.81M | $48.68M | $32.35M | $19.11M | $18.58M | $15.44M | $6.48M | $11.94M | $3.95M | -$4.92M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
| Operating Activities | ||||||||||||||||||||
| Net Income | -$3.35M | -$156.81M | -$117.81M | -$182.03M | -$191.55M | -$138.06M | -$84.49M | -$126.76M | -$53.48M | -$66.75M | -$75.1M | -$73.67M | -$39.8M | -$38.44M | -$28.55M | -$29.25M | -$21.09M | -$23.83M | -$23.09M | -$22.78M |
| Depreciation & Amortization | $964K | $950K | $920K | $952K | $1.39M | $1.62M | $1.79M | $962K | $551K | $300K | $209K | $326K | $302K | $320K | $435K | $472K | $451K | $434K | $375K | $232K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | -$12.01M | $0 | -$12.93M | $0 | $5.59M | $1.31M | $854K | $41K | $511K | $28.55M | $329K | $34K | $294K | -$145K | -$262K |
| Stock-Based Compensation | $8.19M | $10.49M | $11.65M | $0 | $0 | $14.93M | $13.79M | $11.71M | $12.69M | $13.58M | $9.58M | $8.92M | $6.25M | $4.28M | $1.93M | $2.18M | $1.49M | $2.31M | $6.06M | $1.44M |
| Changes in Working Capital: | ||||||||||||||||||||
| Accounts Receivable | $30.45M | $40.01M | $245.72M | -$175.07M | -$34.31M | $31.34M | -$12.37M | -$6.17M | -$5.11M | -$5.52M | -$6.13M | -$13K | $2K | -$1K | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | -$208K | -$1.06M | $355K | $685K | -$656K | $96K | -$568K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | -$10.66M | $14.64M | -$19.74M | $13.28M | $10.54M | $9.52M | -$319K | $4.2M | $5.46M | -$1.17M | $957K | $1.46M | $1.46M | -$140K | $0 | $0 | $0 |
| Other Working Capital | $3.27M | -$10.27M | $1.7M | $66.76M | $5.57M | -$3.82M | -$251K | -$435K | -$5.27M | $282K | -$429K | -$85K | $4.17M | -$2.53M | -$1.3M | $10.13M | $818K | -$892K | $1.99M | $0 |
| Total Working Capital Change | $33.72M | $29.74M | $247.42M | -$118.97M | -$14.11M | $7.58M | -$394K | $4.29M | -$172K | -$6.21M | -$2.26M | $4.79M | $3M | -$1.57M | $164K | $11.6M | $678K | -$892K | $1.99M | $305K |
| Other Non-Cash Items | -$155.62M | -$33.17M | -$67.45M | $213.56M | $94.54M | $25.86M | $9.23M | $18.98M | $4.19M | $1.98M | $1.04M | $738K | $502K | $354K | -$28.19M | $174K | -$595K | $2M | $503K | $10.89M |
| Net Cash from Operating | -$116.09M | -$148.8M | $74.73M | -$86.48M | -$109.72M | -$100.09M | -$60.07M | -$103.74M | -$36.23M | -$51.5M | -$65.21M | -$58.04M | -$29.7M | -$34.55M | -$25.67M | -$14.5M | -$19.03M | -$19.67M | -$14.31M | -$10.17M |
| Investing Activities | ||||||||||||||||||||
| Capital Expenditures | -$65K | -$165K | -$426K | -$113K | -$277K | -$283K | -$334K | -$567K | -$350K | -$126K | -$240K | -$28K | -$204K | -$642K | -$1.24M | -$8.44M | -$279K | -$164K | -$534K | -$166K |
| Acquisitions | $0 | $0 | $0 | $0 | $125.99M | $0 | $3K | $0 | $0 | $126K | $240K | $28K | $0 | $0 | $33K | $0 | $76K | $0 | $0 | -$212K |
| Purchases of Investments | -$185.31M | -$987.38M | -$1.02B | -$429.05M | -$32.01M | -$133.19M | -$58.22M | -$68.78M | -$65.33M | -$73.97M | -$91.77M | -$58.85M | -$47.18M | -$49.55M | -$9M | -$57.77M | -$64.21M | $0 | -$30.56M | -$9.54M |
| Sales of Investments | $109.9M | $1.07B | $1.05B | $301.59M | $100M | $66.45M | $55.15M | $94.5M | $28.08M | $57.76M | $71.4M | $65.03M | $55.3M | $49.28M | $27.15M | $78.5M | $12.08M | $10.73M | $25M | $9.34M |
| Other Investing Activities | $240M | $0 | $0 | $0 | $0 | $0 | -$3K | $26K | -$37K | -$126K | -$240K | -$28K | $8K | -$265 | -$33K | $7.63M | -$76K | $0 | $0 | $0 |
| Net Cash from Investing | $164.52M | $82.22M | $27.45M | -$127.56M | $193.71M | -$67.03M | -$3.4M | $25.15M | -$37.6M | -$16.34M | -$20.61M | $6.16M | $7.91M | -$907K | $16.91M | $19.92M | -$52.4M | $10.57M | -$6.09M | -$579K |
| Financing Activities | ||||||||||||||||||||
| Debt Repaid | $89.16M | $41.34M | $101.58M | -$123.83M | $1.82M | -$98.2M | $1.14M | -$109.62M | $431K | -$24.16M | -$15.33M | -$11.48M | - | -$298K | -$8.89M | $3.26M | $4.12M | -$15.87M | $1M | $391K |
| Common Stock Issuance | $46.99M | $0 | $0 | $415K | $8.38M | $93.67M | $54.24M | $6.73M | $63.66M | $38.04M | $79.08M | $37.75M | $20.99M | $32.31M | $595K | $299K | $61.84M | $40K | $360K | $0 |
| Common Stock Repurchases | $0 | -$11.85M | -$4.65M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.15M | $0 | -$48K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $116.07M | $150K | $0 | -$241K | -$17.34M | $7.6M | -$28.57M | $11.77M | $6.5M | -$7.58M | $1.62M | $662K | $369K | $595K | $299K | $0 | $0 | $239K | $126K |
| Net Cash from Financing | -$42.17M | $62.88M | -$106.08M | $124.25M | $6.32M | $174.53M | $60.7M | $81.05M | $75M | $68.7M | $86.83M | $50.86M | $21.65M | $32.97M | $9.49M | -$2.96M | $59.52M | $15.91M | $2.93M | $33.9M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $6.26M | -$3.71M | -$3.9M | -$89.8M | $90.31M | $7.42M | -$2.78M | $2.47M | $1.17M | $859K | $1.01M | -$1.03M | -$136K | -$2.48M | $727K | $2.46M | -$11.91M | $6.8M | -$17.48M | $23.15M |
| Supplementary Data | ||||||||||||||||||||
| Operating Cash Flow | -$116.09M | -$148.8M | $74.73M | -$86.48M | -$109.72M | -$100.09M | -$60.07M | -$103.74M | -$36.23M | -$51.5M | -$65.21M | -$58.04M | -$29.7M | -$34.55M | -$25.67M | -$14.5M | -$19.03M | -$19.67M | -$14.31M | -$10.17M |
| Capital Expenditure | -$65K | -$165K | -$426K | -$113K | -$277K | -$283K | -$334K | -$567K | -$350K | -$126K | -$240K | -$28K | -$204K | -$642K | -$1.24M | -$8.44M | -$279K | -$164K | -$534K | -$166K |
| Free Cash Flow | -$116.16M | -$148.97M | $74.3M | -$86.6M | -$110M | -$100.37M | -$60.41M | -$104.3M | -$36.58M | -$51.63M | -$65.45M | -$58.07M | -$29.9M | -$35.19M | -$26.91M | -$22.94M | -$19.31M | -$19.84M | -$14.85M | -$10.34M |
| Cash at Beginning | $3.4M | $7.11M | $11.01M | $100.81M | $10.5M | $3.08M | $5.86M | $3.39M | $2.22M | $1.36M | $354K | $1.38M | $1.52M | $4M | $3.28M | $820K | $12.73M | $5.92M | $23.4M | $253K |
| Cash at End | $9.66M | $3.4M | $7.11M | $11.01M | $100.81M | $10.5M | $3.08M | $5.86M | $3.39M | $2.22M | $1.36M | $354K | $1.38M | $1.52M | $4M | $3.28M | $820K | $12.73M | $5.92M | $23.4M |